Company Cryo-Cell International, Inc. Other OTC

Equities

CCEL

US2288951088

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Healthcare Facilities & Services

Inactive Instrument

Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.

USD in Million	2022	Weight	2023	Weight	Delta
Umbilical Cord Blood and Cord Tissue Stem Cell Service 98.3 %	30	98.1 %	31	98.3 %	+3.44%
Public Cord Blood Banking 1.5 %	0	1.5 %	0	1.5 %	+4.23%
PrepaCyte Cord Blood 0.2 %	0	0.3 %	0	0.2 %	-36.10%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	30	100.0 %	31	100.0 %	+3.32%

Managers	Title	Age	Since
Mark Portnoy CEO	Chief Executive Officer	60	11-07-31
David Portnoy CEO	Chief Executive Officer	61	11-07-31
Jill Taymans DFI	Director of Finance/CFO	55	97-03-31
Joanne Kurtzberg CTO	Chief Tech/Sci/R&D Officer	-	17-12-31
Oleg Mikulinsky CTO	Chief Tech/Sci/R&D Officer	50	12-03-04
Irene Smith IRC	Investor Relations Contact	-	-

Members of the board	Title	Age	Since
David Portnoy CEO	Chief Executive Officer	61	11-07-31
Mark Portnoy CEO	Chief Executive Officer	60	11-07-31
Harold Berger BRD	Director/Board Member	60	11-08-24
Daniel Mizrahi BRD	Director/Board Member	50	21-09-19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	14,698,746	3,868,118 ( 26.32 %)	6,594,269 ( 44.86 %)	26.32 %

Name	Equities	%	Valuation
David Portnoy 16.45 %	1,362,976	16.45 %	10 M $
Mark Portnoy 11.29 %	935,768	11.29 %	7 M $
Charles Nyberg 7.240 %	600,000	7.240 %	4 M $
Adam Fleishman 6.142 %	509,000	6.142 %	4 M $
Hamilton Lane Advisors LLC 4.944 %	409,734	4.944 %	3 M $
JOHNSON & JOHNSON 2.511 %	208,101	2.511 %	2 M $
SFI Advisors LLC 1.995 %	165,300	1.995 %	1 M $
The MassMutual Trust Co., FSB 1.340 %	111,035	1.340 %	828 321 $
Vanguard Group, Inc. (Subfiler) 1.100 %	91,139	1.100 %	679 897 $
Oleg Mikulinsky 1.018 %	84,349	1.018 %	629 244 $

Cryo-Cell International, Inc.

700 Brooker Creek Boulevard Suite 1800

34677, Oldsmar

+813 749 2100

http://www.cryo-cell.com

address Cryo-Cell International, Inc.(CCEL)

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Other Healthcare Facilities & Services

	1st Jan change	Capi.
CVS HEALTH CORPORATION	-14.73%	85.42B
HCA HEALTHCARE, INC.	+16.05%	84.38B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+10.92%	29.39B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-12.73%	17.49B
FRESENIUS SE & CO. KGAA	-3.17%	16.44B
QUEST DIAGNOSTICS INCORPORATED	-1.78%	15.28B
FRESENIUS MEDICAL CARE AG	-0.45%	12.22B
PURE HEALTH HOLDING	-31.23%	11.98B
EUROFINS SCIENTIFIC SE	-2.51%	11.71B

Other Healthcare Facilities & Services